Skip to Main Content

Paper Details

Identifying treatment options for BRAFV600 wild-type metastatic melanoma: A SU2C/MRA genomics-enabled clinical trial.
PLoS One
5
2021
Author NameAffiliation
Winnie S LiangTranslational Genomics Research Institute
John D CarptenKeck School of Medicine, University of Southern California
David W CraigKeck School of Medicine, University of Southern California
Alan H BryceMayo Clinic
Jeffrey A KieferTranslational Genomics Research Institute
Sara NasserTranslational Genomics Research Institute
Sara A ByronTranslational Genomics Research Institute
Jonathan J KeatsTranslational Genomics Research Institute
Emanuel F PetricoinCenter for Applied Proteomics and Molecular Medicine, George Mason University
Emanuel F PetricoinCenter for Applied Proteomics and Molecular Medicine, George Mason University
Nicholas J SchorkTranslational Genomics Research Institute
Richard W JosephMayo Clinic
  • 1 - 12

Datasets

Release 1.2